Total Number of Shares and Voting Rights
On April 30, 2020
| Total number of outstanding shares |
Theoretical voting rights | Exercisable voting rights (minus treasury shares) |
| 67,762,234 | 67,762,234 | 67,391,300 |
Last updated on
Last updated on
Onxeo designs and develops novel oncology drugs targeting tumor DNA repair functions.